Financhill
Back

Portage Biotech Stock Predictions

Portage Biotech Stock Forecast

  • Is Portage Biotech Stock Undervalued?
    The current Portage Biotech [PRTG] share price is $3.00. The Score for PRTG is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • PRTG is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Portage Biotech Stock Go Up Next Year?

Data Unavailable

Portage Biotech Stock Rating

Data Unavailable

Portage Biotech Stock Price History

Is PRTG stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRTG is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
British Virgin Islands
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
portagebiotech.com

52-Week Data

52-Week High:
40.80
52-Week Low:
2.10

Prediction Charts

Market Cap:
3.36M
Price in USD:
3.00
Volume:
34.3K
Beta:
39.92

Technical Analysis

SMA50:
5.07
SMA100:
4.78
SMA200:
5.74
52-Wk Change:
-87.4%

Stock Predictions

  • Is Portage Biotech stock public?
    Yes, Portage Biotech is a publicly traded company.
  • What is the Portage Biotech stock quote today?
    The Portage Biotech stock price is 3.00 USD today.
  • How to buy Portage Biotech stock online?
    You can buy Portage Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 4.39 4.72 5.00 4.37
Nov-26 4.73 4.87 4.94 4.59
Nov-27 4.80 4.21 4.99 4.20
Nov-29 4.20 4.19 4.53 4.09
Dec-2 4.15 4.04 4.45 3.96
Dec-3 4.10 3.98 4.15 3.92
Dec-4 4.13 4.11 4.24 4.11
Dec-5 4.10 4.03 4.10 3.99
Dec-6 4.08 4.13 4.20 3.95
Dec-9 4.13 4.16 4.16 3.99
Dec-10 3.97 3.87 4.09 3.46
Dec-11 3.78 3.81 4.06 3.66
Dec-12 3.94 3.82 4.13 3.76
Dec-13 3.47 3.00 3.55 2.95

Portage Biotech Earnings

Data Unavailable

Portage Biotech Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.89 per share, and an increase next year of $0.04 per share.

* Portage Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.